Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs.
about
Repurposing metformin: an old drug with new tricks in its binding pocketsSerine, glycine and one-carbon units: cancer metabolism in full circleMOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolismThe mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistanceXenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agentsApplication of artificial neural networks to investigate one-carbon metabolism in Alzheimer's disease and healthy matched individualsMedium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer CellsMetformin Improves Diabetic Bone Health by Re-Balancing Catabolism and Nitrogen DisposalMetformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells.Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cellsDeregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Global metabolite profiling of mice with high-fat diet-induced obesity chronically treated with AMPK activators R118 or metformin reveals tissue-selective alterations in metabolic pathwaysMetformin limits the tumourigenicity of iPS cells without affecting their pluripotency.Metformin for cancer and aging prevention: is it a time to make the long story short?Metformin may reduce oral cancer risk in patients with type 2 diabetesHigh efficacy of intravesical treatment of metformin on bladder cancer in preclinical model.One-carbon metabolism: an aging-cancer crossroad for the gerosuppressant metforminPotential applications for biguanides in oncologyA marriage of two "Methusalem" drugs for the treatment of psoriasis?: Arguments for a pilot trial with metformin as add-on for methotrexate.Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transportMetformin use and cervical cancer risk in female patients with type 2 diabetesNutrients in Energy and One-Carbon Metabolism: Learning from Metformin Users.Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus.The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells.Mitochondrial dysfunction: a basic mechanism in inflammation-related non-communicable diseases and therapeutic opportunities.Expanding the therapeutic spectrum of metformin: from diabetes to cancer.Combined transcriptome and metabolome analyses of metformin effects reveal novel links between metabolic networks in steroidogenic systems.A Structural Basis for Biguanide Activity.Metformin use in pregnancy: promises and uncertainties.Complex I inhibition augments dichloroacetate cytotoxicity through enhancing oxidative stress in VM-M3 glioblastoma cells.Metabolic heterogeneity signature of primary treatment-naïve prostate cancer.Metformin suppressed the proliferation of LoVo cells and induced a time-dependent metabolic and transcriptional alteration.Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype.A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.One-Carbon Metabolism in Health and Disease.Acquired resistance to metformin in breast cancer cells triggers transcriptome reprogramming toward a degradome-related metastatic stem-like profile.Oncobiguanides: Paracelsus' law and nonconventional routes for administering diabetobiguanides for cancer treatment.Recent advances in the use of metformin: can treating diabetes prevent breast cancer?Metformin and lung cancer risk in patients with type 2 diabetes mellitus.
P2860
Q22250976-BD082F01-FA3E-44B4-A0F7-B67B5CBAB51AQ26828610-2209B07C-93D1-486D-8B82-313D5517C62BQ28067635-F0D47423-03E3-46C0-840F-8CA2302D9FF0Q28116902-29BA7425-BD57-4953-8259-C7162FA16D3DQ28395443-BD676EFB-F42E-48D6-84EF-072CD3AC276DQ28535239-F800A3CA-0151-42B0-857B-AE9FE602A85EQ28551723-EFC4CA2E-49D5-43EC-884E-233028CC11F2Q28551882-678AD037-2B26-4D82-83BA-55A5D8094E95Q33971668-1A3F2A2E-4AAB-45AC-99BD-75627A19BA1FQ34100885-3F3B52C7-08CB-4C1C-9DEA-3EEB638665E2Q34103963-7AB7C864-50A3-4C55-8956-B009BE736E8EQ35275058-B95D32D3-C8CF-4592-9597-0F06FD7B707BQ36460656-0313FAEE-015A-4CB3-BF5D-8D77758E6155Q36545393-82B2E45D-B674-4ABB-BF95-22610F1AD68FQ36739022-B8D4DA1E-C97B-4E55-8437-9736C5C64115Q36962520-B660C676-ADBD-43F1-AEAE-5589F49D447AQ37001540-FA6E20DE-0016-43DC-A3C6-2454D8E20FE9Q37123877-12DAC721-B52C-4CC8-A33C-D81AF73A6221Q37170305-DB10C6E7-1D7A-45CB-B6ED-104797A64378Q37274957-1D712A80-4DC7-4B48-AF86-9C9F9F35E7C3Q37588301-7824B509-9A07-4DDC-B39B-866A58D69A64Q37644891-78633379-D168-4F00-ABFA-52BED8492D5FQ37673171-CBDC5759-AC04-435F-B9BF-7558CC4202DCQ37745840-580FE8C9-00D0-4A1B-89E8-2276A1A7F69CQ38071479-274500DA-C5B1-40FA-9B6F-6F5BA089A9B5Q38093566-E06D630C-9F72-455D-B9C3-AE10C18037C5Q38558943-716C1175-1872-4187-B435-D452EF538362Q38619155-D3323D42-2BAD-4348-91AB-5C213A0F094AQ38647178-B77E182A-DD8B-46EC-8154-E1724BC51554Q38647784-7475CD2F-ED57-48A0-8B65-D11C4BA99262Q38711927-37C09887-9A5A-4979-A609-F1A9167A9C3EQ38810786-E2731A2B-0399-478E-9126-4C0A108A5809Q38816034-06290DDF-6375-4DE8-B69D-1BDD659F72FAQ38874166-725B860A-EC7A-4C29-B7AC-90637280B258Q38885892-3976F2DF-D27A-41C1-911E-B927B914A515Q38957946-7DED3C32-3B4C-42C4-BA4D-E9689E26C2E4Q39247899-D6B3C221-6268-491B-AD32-8A48F6454C5DQ40720253-AE2634CD-B868-473D-BD7D-7DFDCA45DA9EQ41083568-CAE4A380-9004-4343-A766-6D1D69F52138Q41092838-18D3438E-16A1-4957-AAD1-D32D7CFB7854
P2860
Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Metabolomic fingerprint reveal ...... e class of chemotherapy drugs.
@ast
Metabolomic fingerprint reveal ...... e class of chemotherapy drugs.
@en
type
label
Metabolomic fingerprint reveal ...... e class of chemotherapy drugs.
@ast
Metabolomic fingerprint reveal ...... e class of chemotherapy drugs.
@en
prefLabel
Metabolomic fingerprint reveal ...... e class of chemotherapy drugs.
@ast
Metabolomic fingerprint reveal ...... e class of chemotherapy drugs.
@en
P2093
P2860
P356
P1433
P1476
Metabolomic fingerprint reveal ...... e class of chemotherapy drugs.
@en
P2093
Alejandro Vazquez-Martin
Antonio Segura-Carretero
Bruna Corominas-Faja
Cristina Oliveras-Ferraros
Javier A Menendez
Jorge Joven
Rosa Quirantes-Piné
Sílvia Cufí
Vicente Micol
P2860
P304
P356
10.18632/AGING.100472
P577
2012-07-01T00:00:00Z